USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH ADVANCED ACTIVE RHEUMATOID ARTHRITIS. 2022

Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
Dubrava University Hospital, Department of Physical and Rehabilitation Medicine with Rheumatology, Zagreb, Croatia.

This study aimed to determine whether patients with active rheumatoid arthritis (RA) regularly take non-steroidal anti-inflammatory drugs (NSAIDs) and to clarify whether their decision to take NSAIDs depends on disease activity, intensity of pain, or functional status. The study also aimed to identify the risk factors for gastrointestinal side effects. Over 6 months, we conducted a cross-sectional single-center study of consecutively hospitalized patients with confirmed RA. Activities of daily living, pain intensity, and disease activity were evaluated by the Health Assessment Questionnaire, visual analog scale, and disease activity score, respectively, in 28 joints. Of 73 patients diagnosed with RA, 48 (66%) regularly took NSAIDs. Compared to non-users, NSAID users used glucocorticoids less frequently. The decision to use NSAIDs was independent of disease activity, pain intensity, degree of functional impairment, or presence of gastrointestinal risk factors. However, a higher degree of functional impairment was associated with a longer duration of continuous NSAID and glucocorticoid use. NSAIDs are still relevant for RA treatment. The decision to use them is not necessarily affected by disease activity or pain intensity, but their prolonged use is required in patients with a higher degree of functional disability. NSAIDs enable exclusion of glucocorticoid use, sparing patients of glucocorticoid-related side effects.

UI MeSH Term Description Entries
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000203 Activities of Daily Living The performance of the basic activities of self care, such as dressing, ambulation, or eating. ADL,Chronic Limitation of Activity,Limitation of Activity, Chronic,Activities, Daily Living,Activity, Daily Living,Daily Living Activities,Daily Living Activity,Living Activities, Daily,Living Activity, Daily
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
January 1984, Terapevticheskii arkhiv,
Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
March 1984, British journal of clinical pharmacology,
Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
December 1994, Revue du rhumatisme (Ed. francaise : 1993),
Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
January 1991, European journal of rheumatology and inflammation,
Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
September 1980, British medical journal,
Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
January 1982, Clinical pharmacokinetics,
Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
January 1986, The Quarterly journal of medicine,
Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
October 1993, Acta paediatrica Japonica : Overseas edition,
Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
July 1982, Maryland state medical journal,
Dubravka Bobek, and Andrea Banić Stipetić, and Miljenko Franić, and Marko Lucijanić, and Jelena Lucijanić, and Ana Gudelj Gračanin, and Luciana Mijačika, and Porin Perić
February 2004, Scandinavian journal of gastroenterology,
Copied contents to your clipboard!